Clinical Trials Logo

Healthy clinical trials

View clinical trials related to Healthy.

Filter by:

NCT ID: NCT06441396 Completed - Healthy Clinical Trials

Comparison of Telerehabilitation and Video Basics and Exercise in Older Adult Individuals

Start date: January 31, 2002
Phase: N/A
Study type: Interventional

Researchers could not find a study in the literature examining the effectiveness of different technological methods in exercise practices in older adults. Based on this, the aim of this study is to compare the effect of exercise intervention using telerehabilitation and video-based rehabilitation method on physical performance, muscle mass, fat percentage and body mass index.

NCT ID: NCT06441188 Not yet recruiting - Healthy Clinical Trials

Sonography of the Nipple Areolar Complex

Start date: June 5, 2024
Phase: N/A
Study type: Interventional

The purpose of this study is to determine ultrasound scanning techniques of the nipple areolar complex (NAC) that provide optimal diagnostic imaging features.

NCT ID: NCT06440980 Not yet recruiting - Healthy Clinical Trials

A Study to Compare Tablets and Capsules of Orforglipron (LY3502970) in Healthy Participants Who Are Obese or Overweight

Start date: June 24, 2024
Phase: Phase 1
Study type: Interventional

The main purpose of this study is to see how much of orforglipron (study drug) gets into the bloodstream and how long it takes the body to get rid of it when given as capsules compared to tablets in healthy overweight and obese participants. The safety and tolerability (side effects) of orforglipron when given as capsules and tablets will also be evaluated. The study will be conducted in two parts, with part A and B lasting up to approximately 25 and 22 weeks each, including the screening period.

NCT ID: NCT06437314 Not yet recruiting - Healthy Clinical Trials

Effect of an Intervention Based on Back School in an Aquatic Environment on Non-specific Low Back Pain

Start date: July 10, 2024
Phase: N/A
Study type: Interventional

A controlled and randomized clinical trial will be conducted, in which scores on dependent variable measures will be compared before and after the intervention, both in the experimental group (EG) (individuals who will attend the in an aquatic program based on the back school) and in the control group (CG) (individuals who will not attend the in an aquatic program based on the back school). The experimental procedure will follow the recommendations of the CONSORT and TidIER guidelines. The study protocol will be approved by the Research Ethics Committee of the University of Vigo. This study will be conducted under the Declaration of Helsinki (2013 version). Participants will sign a written informed consent after being informed of the benefits and risks of the research. Participants in the EG will participate in an aquatic program based on the back school. This program will follow the recommendations of the biopsychosocial model of chronic pain and will be conducted in an aquatic environment. The intervention will be carried out by physiotherapists in a sports centre. The duration of the intervention will be six weeks, with a frequency of two sessions per week, totalling 12 sessions of 45 minutes each. Of all the sessions, 10 will have a practical focus and the other two will have a theoretical focus.

NCT ID: NCT06437262 Completed - Healthy Clinical Trials

Antibacterial Effect and Substantivity of a New Chlorhexidine and Cymenol Gel on Oral Biofilm and Saliva

Start date: September 1, 2022
Phase: Phase 1
Study type: Interventional

The objective of this project was to compare the immediate antimicrobial effect and in situ substantivity of a new 0.20% chlorhexidine (CHX) gel and cymenol with the current CHX gel formulation on dental plaque biofilm and salivary flora up to 7 hours after a single application.

NCT ID: NCT06435819 Not yet recruiting - Healthy Clinical Trials

ECA-enhanced Document Explanation RCT

Start date: September 1, 2026
Phase: N/A
Study type: Interventional

The investigators will evaluate a computer-animated character that explains medical illustrations to people, comparing the character to having people understand the illustrations on their own, and also comparing the computer character on a computer display to one in immersive virtual reality. The investigators will determine which method leads to the best understanding and lowest anxiety.

NCT ID: NCT06435806 Recruiting - Healthy Clinical Trials

Medical Illustration Design Characteristic Evaluation

Start date: March 25, 2024
Phase: N/A
Study type: Interventional

The goal of this study is to understand what people understand from medical illustrations, and what meaning and emotions (such as anxiety) they derive from different design elements.

NCT ID: NCT06435442 Not yet recruiting - Healthy Clinical Trials

PK,PD and DDI of Epaminurad and Naproxen in Healthy Volunteers

Start date: May 2024
Phase: Phase 1
Study type: Interventional

A Phase 1 Study to evaluate the safety, PK/PD, drug-drug interaction(DDI) of Epaminurad and Naproxen in Healthy Volunteers

NCT ID: NCT06434181 Completed - Healthy Clinical Trials

Beetroot Juice for Boosting Immunity During a Time of Stress.

Start date: April 11, 2022
Phase: Phase 2
Study type: Interventional

The purpose of the present study is to explore the effects of a dietary nitrate supplement (i.e., beetroot juice) on nitric oxide levels, immunity, mood, and cardiovascular activity during and following final exam stress in healthy individuals.

NCT ID: NCT06434038 Not yet recruiting - Healthy Clinical Trials

Measurement of Insulin Levels in the Cerebrospinal Fluid of Healthy Adults After a Single Intranasal Dose - Middle Age

INI-CSF-MA
Start date: October 1, 2024
Phase: Phase 1
Study type: Interventional

The purpose of this study is to find out whether insulin, a drug approved by the FDA for the treatment of diabetes mellitus, reaches the brain and spinal cord when delivered as a nasal spray (intranasally). Intranasal insulin has been shown to improve memory and mood in patients with neurological diseases such as mild cognitive impairment and dementia, but more evidence is needed to support the ability to effectively target the brain through intranasal routes. 18 healthy middle-aged adults will be randomly assigned to receive a single intranasal dose of 40 units insulin ("low dose" group), 80 units insulin ("high dose" group), or saline (placebo, or control group). Participants will undergo an image-guided lumbar puncture (spinal tap) performed by a study clinician. Samples of cerebrospinal fluid (a fluid surrounding the brain and spinal cord) and blood will be collected at 5 timepoints during the lumbar puncture: once prior to the administration of intranasal insulin, and again at 10, 20, 30, and 40 minutes after the dose is given. Samples will be tested to determine the level of insulin detected in the cerebrospinal fluid and blood at each time point. Results of this study will provide essential information about the ability of insulin to reach the brain after intranasal administration.